Magrolimab (Hu5F9-G4) promotes macrophage M1 polarization and is associated with enhanced autophagy in colorectal cancer.

Saved in:
Bibliographic Details
Title: Magrolimab (Hu5F9-G4) promotes macrophage M1 polarization and is associated with enhanced autophagy in colorectal cancer.
Authors: Lin WR; Department of Surgical Oncology, The First Affiliated Hospital of Kunming Medical University, Kunming 650032, China., Liu WQ; Department of Internal Medicine-Oncology, The First Affiliated Hospital of Kunming Medical University, Kunming 650032, China., Alburiahi TAH; Department of Surgical Oncology, The First Affiliated Hospital of Kunming Medical University, Kunming 650032, China., Chen RB; Department of Surgical Oncology, The First Affiliated Hospital of Kunming Medical University, Kunming 650032, China., Lu HP; Department of Surgical Oncology, The First Affiliated Hospital of Kunming Medical University, Kunming 650032, China., Dong J; Colorectal Cancer Clinical Research Center, Yunnan Cancer Hospital, Kunming 650118, China. Electronic address: dongjian1@kmmu.edu.cn., Yang J; Department of Surgical Oncology, The First Affiliated Hospital of Kunming Medical University, Kunming 650032, China. Electronic address: yangjun6@kmmu.edu.cn.
Source: Translational oncology [Transl Oncol] 2026 Jan; Vol. 63, pp. 102598. Date of Electronic Publication: 2025 Nov 10.
Publication Type: Journal Article
Journal Info: Publisher: Neoplasia Press Country of Publication: United States NLM ID: 101472619 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1936-5233 (Print) Linking ISSN: 19365233 NLM ISO Abbreviation: Transl Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first